What analyst predict for Avid Bioservices NASDAQ:CDMO?


What analyst predict for Avid Bioservices NASDAQ:CDMO?

Avid Bioservices NASDAQ:CDMO headquartered in Scotts Valley, California, United States is reporting their earnings on 07/16/2018 before the bell. Street forecast for the quarter ending March 2018 is $-0.15.

According to stock market daily analyst this is Lower then same time previous year. Avid Bioservices, reported EPS for the same quarter last year was $-0.16



Overview of Avid Bioservices NASDAQ:CDMO

Avid Bioservices, Inc. operates as a contract development and manufacturing organization focusing on the development and cGMP manufacture of biopharmaceutical products derived from mammalian cell culture. It provides a range of process development, and cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The company produces monoclonal antibodies and recombinant proteins in batch, fed-batch, and perfusion modes; and provides services, including cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing, and regulatory strategy, submission, and support. It also offers various process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development, and product characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. is based in Tustin, California.

% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Dividend Rate